What's new at Łukasiewicz – PORT?
- Reading time: 3 min.
The PORTfolio podcast series at Łukasiewicz – PORT was born out of a passion for science and a fascination with human stories. These conversations bring together researchers at different stages of their careers – from early-career scientists taking their first steps in the world of research to experienced experts, innovators, and leaders in their fields. They talk about their professional paths, the challenges they have encountered, and how they balance scientific work with life beyond the laboratory.
- Reading time: 3 min.
On 22 April 2025, Łukasiewicz – PORT hosted 18 students from Wrocław University of Science and Technology and the University of Wrocław for a one-day workshop organized as part of the SAME-NeuroID Spring School. The event, held onsite in Wrocław, provided participants with a valuable opportunity to deepen their understanding of neurobiology and to discuss potential career paths with researchers from the SAME-NeuroID network.
- Reading time: 3 min.
Witold Konopka, Patrycja Gazińska, Michał Ślęzak, Grzegorz Chodaczek, Michał Malewicz, Agnieszka Krzyżosiak i Anna Nosal – oto zespół projektu P4Health, który znalazł się właśnie wśród 30 Kreatywnych Wrocławia.
- Reading time: 2 min.
PORT for Health: Neuroscience 2025 once again brought world-class neuroscience experts, clinicians and entrepreneurs to Łukasiewicz – PORT. This year’s edition focused on innovative approaches to understanding brain disorders, including neuroimmune interactions and the use of advanced computational tools to study behaviour and neurodegeneration.
- Reading time: 2 min.
Dr Dominik Kowal from the Materials for Photonics Research Group at Łukasiewicz – PORT discusses the current state of research on nuclear batteries and their potential applications. He is the first author of the paper “Current trends in material research for nuclear batteries: Harnessing metal perovskite halides and other chalcogenides for greater compactness and efficiency”, published in March in Applied Physics Reviews, a journal issued by the American Institute of Physics.
- Reading time: 2 min.
Once again, Łukasiewicz – PORT will host scientists, clinicians, and entrepreneurs connected with the field of neurobiology. This year, however, the conference will be organized for the first time under the banner of P4Health, a strategic project for Łukasiewicz – PORT. Thanks to support from the Teaming for Excellence programme of Horizon Europe, the Institute is implementing activities aimed, among others, at optimizing the diagnosis of neurobiological diseases. These topics will be at the heart of discussions during the conference, which begins on 7 April.
- Reading time: 3 min.
Another seminar organized within the SAME–NeuroID project will focus on the latest therapeutic strategies for patients suffering from amyotrophic lateral sclerosis (ALS). Professor Richard Robitaille from the Department of Neurosciences at the University of Montreal will give his lecture on 3 April at 14:00 at Łukasiewicz – PORT.
- Reading time: 3 min.
Representatives of partner institutions, local governments, scientific and educational organizations from the Polish–Saxon border region, as well as all those interested in the planned activities, met on 25 March at the Bolesławiec Cultural Centre for the inauguration of the Cross-Border Experience Gardens project.
- Reading time: 2 min.
As part of the SAME-NeuroID project, which aims to develop more effective diagnostic methods and therapies for psychiatric patients, a scientific seminar entitled “Application of AI Techniques in Medical Imaging” has been scheduled. The seminar will take place on 27 March at 2:00 PM and will be delivered by Dr Martin Tabakow from Wrocław University of Science and Technology, a specialist in the analysis and processing of medical images using advanced artificial intelligence techniques.
- Reading time: 4 min.
Patients diagnosed with breast cancer often hear from doctors that cancer is not a death sentence. Modern medicine offers a range of treatment options depending on the stage of the disease: surgery, chemotherapy, radiotherapy, or costly monoclonal antibody therapies. Unfortunately, mortality among patients remains high: in 2022, 2.3 million breast cancer cases were diagnosed worldwide, of which 670,000 were fatal (WHO data).
